List of Excipients in API dolutegravir sodium and lamivudine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dolutegravir sodium and lamivudine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
ViiV Healthcare Company | DOVATO | dolutegravir sodium and lamivudine | 49702-246 | CELLULOSE, MICROCRYSTALLINE | 2031-01-24 |
ViiV Healthcare Company | DOVATO | dolutegravir sodium and lamivudine | 49702-246 | HYPROMELLOSE | 2031-01-24 |
ViiV Healthcare Company | DOVATO | dolutegravir sodium and lamivudine | 49702-246 | MAGNESIUM STEARATE | 2031-01-24 |
ViiV Healthcare Company | DOVATO | dolutegravir sodium and lamivudine | 49702-246 | MANNITOL | 2031-01-24 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for dolutegravir sodium and lamivudine
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dolutegravir sodium and lamivudine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
dolutegravir sodium and lamivudine drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dolutegravir sodium and lamivudine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dolutegravir sodium and lamivudine drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
dolutegravir sodium and lamivudine drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
dolutegravir sodium and lamivudine drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
dolutegravir sodium and lamivudine drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
dolutegravir sodium and lamivudine drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dolutegravir sodium and lamivudine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
>Company | >Ingredient | >NDC |
dolutegravir sodium and lamivudine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.